Intended for healthcare professionals

News Roundup [abridged Versions Appear In The Paper Journal]

FDA issues advice to women taking hormone replacement therapy

BMJ 2003; 327 doi: (Published 18 September 2003) Cite this as: BMJ 2003;327:641
  1. Deborah Josefson
  1. Nebraska

    The US Food and Drug Administration, together with the Department of Health and Human Services and the National Institutes of Health, has launched an educational campaign to inform women about the risks and benefits of post-menopausal hormone replacement therapy (HRT).

    The US Congress directed the FDA to develop information material after a number of studies found that HRT was associated with an increased risk of developing certain conditions, including …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription